MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control-Reference-Cited by-同舟云学术

MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control

Published:2023-06-01 Issue:6 Volume:25 Page:404-413
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Lombardo Fortunato¹,Passanisi Stefano¹^ORCID,Alibrandi Angela²,Bombaci Bruno¹,Bonfanti Riccardo³,Delvecchio Maurizio⁴^ORCID,Di Candia Francesca⁵,Mozzillo Enza⁵^ORCID,Piccinno Elvira⁴,Piona Claudia Anita⁶^ORCID,Rigamonti Andrea³,Scialabba Francesco³,Maffeis Claudio⁶^ORCID,Salzano Giuseppina¹

Affiliation:

1. Department of Human Pathology in Adult and Developmental Age “Gaetano Barresi,” University of Messina, Messina, Italy.

2. Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Messina, Italy.

3. Diabetes Research Institute, San Raffaele Hospital, Milano, Italy.

4. Metabolic Disease and Genetics Unit, Giovanni XXIII Children's Hospital, Bari, Italy.

5. Department of Translational Medical Science, Section of Pediatrics, Regional Center of Pediatric Diabetes, Federico II University of Naples, Naples, Italy.

6. Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2022.0491

Reference39 articles.

1. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents

2. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

3. Technology in the management of type 1 diabetes mellitus — current status and future prospects

4. New closed-loop insulin systems

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Technologies and Therapeutics for Type 1 Diabetes;Endocrinology and Metabolism Clinics of North America;2024-03

2. Discordance between Glucose Management Indicator and Glycated Hemoglobin in a Pediatric Cohort with Type 1 Diabetes: A Real-World Study;Children;2024-02-06

3. Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm;Diabetes Technology & Therapeutics;2024-01-26

4. Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review;Diabetes Therapy;2023-12-01

5. Safety and Glycemic Outcomes During the MiniMed^TM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes;Diabetes Technology & Therapeutics;2023-11-01